SEC Form 4 · accession 0001140361-16-065584
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerome M Hauer
Director
Period of report
May 12, 2016
Accepted (ET)
May 16, 2016 · 3:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 12, 2016 | M | 4,700 | $27.93 | A | 18,800 | D | |
| Common StockF1 | May 12, 2016 | S | 4,700 | $38.50 | D | 14,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F2 | $27.93 | May 12, 2016 | M | 4,700 | D | — | Jan 21, 2022 | Common Stock | 4,700 | 9,400 | D |
Explanation of responses
- F1Consists of an option granted under the company's stock incentive plan on January 22, 2015.
- F2The options vest in three equal installments in January 2016, 2017 and 2018.